Cambrex Corporation (Cambrex) is a life sciences company that provides products and services worldwide to pharmaceutical and generic drug companies. The Company's products consist of active pharmaceutical ingredients (APIs) and pharmaceutical intermediates produced under the United States Food and Drug Administration (FDA) current Good Manufacturing Practices (cGMP) for use in the production of prescription and over-the-counter drug products and other fine custom chemicals derived from organic chemistry. In January 2008, Cambrex acquired AS ProSyntest, an API research and development company.